“I can swallow three large tablets at once, and I can write clearly by hand!” A 64-year-old ALS patient who had previously shown no response to riluzole smiled with confidence.

Mrs. Williams, an elegant lady from the United Kingdom, was diagnosed with ALS three years ago. She initially experienced unexplained falls and slow speech, which gradually progressed to slowed movements, muscle weakness, and mild dysphagia. Treatment with riluzole and acetylcysteine yielded no obvious improvement. While her peers enjoyed a free and comfortable retirement, Mrs. Williams was confined by her illness. Normal social activities and outdoor leisure became distant luxuries, and her anxiety only added to her family’s concerns.

Fortunately, after reviewing and verifying reliable information about ALS treatments and patient testimonials online, Mrs. Williams’ family discovered Wu Medical Center (WMC) in Beijing, China. After comparing global options and careful consideration, they traveled to experience the miraculous disease stabilization and symptom improvement brought by Dr. Wu’s unique dual-stem-cell plus CAST therapy.

What made Mrs. Williams’ family confident that their early 2026 treatment trip would be rewarding?

First, as a senior neuroscientist and world-leading expert in clinical stem cell therapy, Dr. Wu has developed an original and distinctive protocol for ALS: neural stem cells combined with mesenchymal stem cells + CAST therapy. This approach has earned worldwide recognition and an excellent reputation among patients. Many ALS patients, once considered incurable, have achieved disease arrest and symptom improvement at Wu Medical Center.

Second, Dr. Wu’s original dual-stem-cell + CAST therapy integrates cutting-edge biological treatments, widely recognized rehabilitation methods, and more than 40 years of comprehensive clinical experience. Its efficacy far exceeds that of single stem cell injections, giving patients and their families greater confidence in this integrated biological, physical, and pharmacological treatment.

Third, as a scholarly clinician, Dr. Wu has continuously explored and upgraded his unique technique through over 30 years of clinical practice and accumulated cases. His treatment helps ALS patients achieve faster, better, more stable, and long-lasting disease control, symptom relief, and quality of life improvement. Many ALS patients have become loyal supporters, trusting that we can truly accompany them to live better and longer.

After just two weeks of inpatient treatment, Mrs. Williams’ motor function improved significantly, with all indicators increasing by at least 30%.

Before treatment, she had mild dysphagia and could only swallow small amounts of soft food.
After treatment, her swallowing function improved, and she could swallow three tablets at once.

Before treatment, muscle strength of her bilateral deltoids and triceps was grade 2+, and other muscle groups grade 3.
After treatment, her deltoids and triceps reached grade 3+, and other muscle groups grade 4.

Before treatment, her left wrist flexion and extension strength was grade 3, left grip strength grade 3; right wrist flexion and extension strength grade 3+, right grip strength grade 3+.
After treatment, wrist flexion and extension strength bilaterally improved to grade 4+, and grip strength nearly grade 5, capable of resisting considerable resistance.

Before treatment, she had poor hand dexterity, significant interosseous muscle atrophy, and was unable to write normally.
After treatment, her hand dexterity improved remarkably; she could write legibly on her daily schedule.

Before treatment, her lower limb strength was grade 3+, she rose slowly from a supine position, could lift both legs for 10 seconds, and had single-leg standing ability of 1–2 seconds on the right and none on the left.
After treatment, lower limb strength reached grade 4+, leg-lift time exceeded 15 seconds, single-leg stance reached 3 seconds on the left and over 6 seconds on the right.

Before treatment, she was prone to falls and mild anxiety.
After treatment, her balance and mobility improved significantly with no falls, and her anxiety was relieved.

Today, Mrs. Williams’ ALS progression has been halted. Her overall motor function has improved by more than 30%. She is relaxed, independent in daily activities, and wears a confident smile.

We hope to help more ALS patients like Mrs. Williams experience the advanced dual-stem-cell plus CAST therapy at WMC, a breakthrough beyond conventional medicine, to stop disease progression, restore motor function, improve quality of life, and face the future with confidence.

To learn more information of Mrs. Williams’ patient story, please refer to the following link:
Mrs Williams-Amyotrophic Lateral Sclerosis (ALS)-(British)